Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals, Inc. (NQ: REGN)
259.96 USD  -3.68 (-1.40%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Regeneron Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
May 21, 2013
May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for... Read More
category companyNews
from Reuters: Company News
Regeneron Pharmaceuticals Shares Up 53.7% Since SmarTrend's Buy Recommendation (REGN)
May 21, 2013
from Comtex SmarTrend® News Briefs
New Asthma Drug Generates Excitement For Patients -- And Its Maker
May 21, 2013
 Read More
category NYSE:MRK , NYSE:SNY , NASDAQ:REGN , and 1 more.
from Forbes Real Time
Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8357210 for the full story. Read More
from StreetInsider.com News Articles
New Asthma Drug Could Be Game Changer
May 21, 2013
 Read More
category NYSE:SNY , NASDAQ:REGN , Hot Stocks
from InvestorPlace - Latest Headlines
Regeneron settles all pending litigation with Roche's Genentech
May 20, 2013
May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap. Read More
category companyNews
from Reuters: Company News
Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356010 for the full story. Read More
from StreetInsider.com News Articles
Earnings Look Back: Regeneron Pharmaceuticals Is Up 0.3% Since Reporting Quarterly Results 2 Weeks Ago (REGN)
May 20, 2013
from Comtex SmarTrend® News Briefs
UBS Starts Regeneron Pharma (REGN) at Neutral
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349692 for the full story. Read More
from StreetInsider.com News Articles
Watch for Continued Gains in Shares of Regeneron Pharmaceuticals (REGN)
May 15, 2013
from Comtex SmarTrend® News Briefs
Sanofi (SNY), Regeneron (REGN) Commence COMPARE, ASCERTAIN of Sarilumab
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339115 for the full story. Read More
from StreetInsider.com News Articles
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
Jim Cramer often advocates themes in the market. These are big picture ideas that he believes will lift the fortunes of companies and by proxy their stocks. Following are 5 themes that he likes right... Read More
category Regeneron Pharmaceuticals Inc , EOG Resources Inc , ENSCO International Incorporated , and 14 more.
from CNBC.com News
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Regeneron's Eylea Drives Astounding Q1 Results
May 10, 2013
Regeneron's (REGN) portfolio of drugs is so small as to raise concerns over having too many eggs in one basket. But its blockbuster drug is a crucial treatment for wet macular degeneration, the leading... Read More
category Investing
from Investor's Business Daily - Investing RSS
Recent 52-Week High Exceeded in Shares of Regeneron Pharmaceuticals (REGN)
May 10, 2013
from Comtex SmarTrend® News Briefs
3 Hot Biotechs to Keep on Your Radar
May 10, 2013
 Read More
category NASDAQ:MEIP , NASDAQ:REGN , NASDAQ:ICPT , and 1 more.
from InvestorPlace - Latest Headlines
MDY, VRTX, REGN, KSU: ETF Outflow Alert
May 08, 2013
Symbols mentioned in this story: MDY, VRTX, REGN, KSU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Regeneron Leads Top 5 Big Cap Stocks By Sales Growth
May 08, 2013
Sales growth is hard to come by in today's sluggish economy. Companies in the big-cap S&P 500 may end up reporting an overall revenue decline in the first quarter. Top-line growth is key continued... Read More
category Screen Center
from Investors.com
UPDATE: Jefferies Raises PT on Regeneron Pharmaceuticals Following Top-Line Q1 Beat
May 06, 2013
In a report published Monday, Jefferies analyst Biren Arnin reiterated a Hold rating on Regeneron Pharmaceuticals (NASDAQ: REGN ), and raised the price target from $179.00 to $247.00. In the report,... Read More
category Benzinga , REGN , Price Target , and 3 more.
from Latest Articles from Benzinga.com
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
Bio-Wire Weekly: April 29 – May 3rd, 2013 To get this email earlier, sign up for our email list The Newsmakers: 1.) Auxilium Pharmaceuticals (NASDAQ: AUXL) Auxilium Pharma was down about 8% in the last... Read More
category Prime Content , AEGR , REGN , and 5 more.
from Bio-Wire.Com
Regeneron Study: EYLEA Growth Potential
May 06, 2013
Regeneron Pharmaceuticals (NASDAQ: REGN) has received an immense amount of attention in the past year, and has doubled the wealth of shareholders primarily due to the shockingly good performance of the... Read More
category REGN , Bio/Wire
from Bio-Wire.Com
Who Got Rich This Week: Pharma Legend P. Roy Vagelos, Chief Yelper Levchin And More
May 04, 2013
Each week at Forbes we scan our database of corporate insiders to see who got richer from the action in the stock market. Thanks to well-received first quarter earnings reports from giants like... Read More
category NASDAQ:THRX , NASDAQ:REGN , NYSE:YELP
from Forbes Real Time
The Best- And Worst-Performing Biotech Stocks, April 26 to May 3
May 04, 2013
These are the best and worst-performing medical and biotech stocks from April 26 to May 3, 2013. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the... Read More
category NASDAQ:SRPT , NASDAQ:INFI , NASDAQ:AVEO , and 2 more.
from Forbes Real Time
Regeneron Pharmaceuticals Surges On Earnings News
May 03, 2013
The number of new 52-week highs was strong for a second straight session Friday, as the overall market surged on upbeat jobs data. Regeneron Pharmaceuticals (REGN) gapped up and bolted 7% to a record... Read More
category New Highs
from Investor's Business Daily - Investing RSS
Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data
May 03, 2013
The U.S. stock market jumped on Friday to end the trading week. The catalyst for the move higher was a strong jobs report, which briefly sent the Dow Jones Industrial Average over 15,000 for the first... Read More
category LNKD , Earnings , Benzinga , and 29 more.
from Latest Articles from Benzinga.com
Brean Capital Upgrades Regeneron Pharma (REGN) to Buy, PT $315
May 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8304201 for the full story. Read More
from StreetInsider.com News Articles
Regeneron Pharmaceuticals (REGN) jumps on Q1 figures
May 03, 2013
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares hiked 8% to $268.54. The Company reported total revenues of $440 million in the first quarter of 2013, compared to $232 million in the first... Read More
from BAYSTREET RSS FEED
Friday’s movers: LinkedIn, Delcath Systems
May 03, 2013
Shares of Regeneron Pharmaceuticals led the S&P 500 in premarket trade on Friday while LinkedIn Corp. and Delcath Systems shares fell. Warren Buffett’s Berkshire Hathaway dominated investor attention. Read More
category LNKD , REGN , Internet Hardware , and 14 more.
from MarketWatch
A Peek Into The Market Before The Trading Starts
May 03, 2013
Pre-open movers US stock futures are slightly lower this morning, as investors are awaiting nonfarm payrolls. Futures for the Dow Jones Industrial Average dropped 8 points to 14,752.00 and S&P 500... Read More
category Benzinga , REGN , RDCM , and 9 more.
from Latest Articles from Benzinga.com
Regeneron raises 2013 Eylea sales view, profit beats Street
May 03, 2013
May 3 (Reuters) - Regeneron Pharmaceuticals Inc's first-quarter results beat analysts' estimates for the seventh straight quarter as the sales of its eye drug Eylea continued to gather pace, and the... Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here